Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$4.08 USD
+0.31 (8.22%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $4.13 +0.05 (1.23%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Metagenomi, Inc. [MGX]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: Metagenomi, Inc.
Industry: Medical - Drugs
Gene Juice: ASGCT Recap - Large Gene Insertion; Epigenetic Editing & More
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Metagenomi, Inc.
Industry: Medical - Drugs
Breadth of Platform on Display at ASGCT; 1Q24 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Metagenomi, Inc.
Industry: Medical - Drugs
The Swiss Army Knife of Genetic Medicine; Initiating at Buy and $10 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Metagenomi, Inc.
Industry: Unclassified
Gene Juice: The Importance of Delivery Vectors - AAVs, LNPs, eVLPs, PNPs, and More
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
|